Dr. Gurinder Shahi, Associate, Chairman
BioEnterprise Asia
Dr. Shahi is a physician with training in molecular biochemistry and international health policy, and management. He is a leading expert on change management and strategic program implementation in healthcare and the life sciences. His experience includes work on life science technology assessment, strategic business planning, R&D and work process improvement, performance appraisal of joint ventures and strategic alliances, market strategy development, economic and policy analysis for health intervention, and evidence-based decision-making for investment and implementation.
Dr. Shahi has worked with leading international organizations and corporations including the Rockefeller Foundation and the United Nations Development Programme. Among other initiatives, he was closely involved with the effort to establish the International Vaccine Institute and the Asia-Pacific International Molecular Biology Network (for which he concurrently served as Executive Director/Coordinator), and has served as advisor and consultant to leading international organizations, governments, corporations and foundations. He has also been actively involved in establishing and providing strategic and management input to a range of start-up enterprises, including: Lynk Biotechnologies, Asia Pacific Genomics, and DNA Phenomics, and in helping a growing number of US, European and, Australian enterprises build their operations in Asia.
He has authored over 50 articles, refereed journal papers and conference presentations, and served as lead editor for "International Perspectives on Environment, Development and Health: Toward a Sustainable World" (Springer Publishing, New York, 1997). He recently wrote the highly acclaimed book, "BioBusiness in Asia: How Asia Can Capitalize on the Life Science Revolution" (Pearson Prentice Hall, 2004).
He is currently a Visiting Scholar/Executive-in-Residence at the University of Southern California's Marshall School of Business. He received his MBBS and PhD from the National University of Singapore, and went on to obtain his MPH in international health policy and management from Harvard University.
